THOMAS KINTANAR: Open Payments
NPI 1750326351 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$47,219 in 179 payments from 27 companies in 2025. Trend: 2023 $33,529 · 2024 $71,054 · 2025 $47,219
Speaker / faculty: $36,434Travel & lodging: $6,617Food & beverage: $4,097Education: $71
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 15 | $17,173 |
| Otsuka America Pharmaceutical, Inc. | 16 | $14,212 |
| Astellas Pharma US Inc | 13 | $8,995 |
| Phathom Pharmaceuticals, Inc. | 9 | $4,516 |
| PFIZER INC. | 24 | $380 |
| ABBVIE INC. | 27 | $262 |
| AstraZeneca Pharmaceuticals LP | 6 | $227 |
| Vanda Pharmaceuticals Inc. | 9 | $216 |
| Lilly USA, LLC | 9 | $202 |
| Sumitomo Pharma America, Inc. | 11 | $157 |
Products named: TZIELD, REXULTI, Veozah, VOQUEZNA, FANAPT, BREZTRI, GEMTESA, CAPLYTA.
Industry payments across IN — which companies pay providers there.
